Document Detail


Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model.
MedLine Citation:
PMID:  12970224     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recurrent stenosis after extended end-to-end anastomosis for aortic coarctation is the primary indication for further interventions in children. Tension because of the extended resection and local arterial wall hypoxia are possible pathogenetic mechanisms. We hypothesized that (1) tension interferes with healing and (2) that vascular endothelial growth factor (VEGF), a hypoxia sensitive angiogenic inducer, may enhance healing of the vascular anastomosis. METHODS AND RESULTS: In a model of coarctation repair, rabbits underwent thoracic aortic end-to-end anastomosis after transection (no-tension; n=15), resection of an aortic ring (tension; n=14) or resection and topical VEGF treatment (0.75 microg VEGF165; tension+VEGF; n=14). Gross and histologic characteristics of the aortic wall were assessed at 1 week, 1 and 2 months. In the tension only group at 1 month, the severity of vascular remodeling was increased with fibrosis and calcification compared with controls. At 2 months, this group also revealed more luminal stenosis (29% versus 19%; P<0.001). Exogenous VEGF resulted in significantly less fibrosis, calcification and chondroid metaplasia at 1 month (P<0.05) and luminal area was only reduced 3% at 2 months (P<0.001 versus tension group). CONCLUSIONS: In a rabbit model of coarctation repair, the addition of tension on the vascular anastomosis resulted in poor healing and luminal stenosis. Topical VEGF maintained luminal integrity by decreasing fibrosis and calcification. These findings suggest that topical VEGF may be a promising new strategy to enhance healing and improve the outcome of vascular anastomoses for coarctation of the aorta.
Authors:
Ralf G Seipelt; Carl L Backer; Constantine Mavroudis; Veronica Stellmach; Ingrid M Seipelt; Mona Cornwell; Jose Hernandez; Susan E Crawford
Related Documents :
23810284 - Effects of knee flexion on the femoropopliteal artery: a computational study.
7847974 - Tailoring aortoplasty for repair of fusiform ascending aortic aneurysms.
3679614 - Cerebellar infarction secondary to subclavian aortoplasty repair for coarctation of the...
708494 - Artefacts of localization of atherosclerosis in pinned aortas.
10072214 - Comparison of immediate and in-hospital results of conventional balloon and perfusion b...
9707334 - Intracranial fungal aneurysm caused by candida endocarditis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  108 Suppl 1     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-12     Completed Date:  2003-09-30     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  II150-4     Citation Subset:  AIM; IM    
Affiliation:
Division of Pediatric Cardiovascular Thoracic Surgery, Children's Memorial Hospital, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Anastomosis, Surgical*
Animals
Aorta, Thoracic / surgery*
Aortic Coarctation / drug therapy*,  pathology,  surgery*
Combined Modality Therapy
Constriction, Pathologic / prevention & control
Endothelial Growth Factors / administration & dosage,  therapeutic use*
Intercellular Signaling Peptides and Proteins / administration & dosage,  therapeutic use*
Lymphokines / administration & dosage,  therapeutic use*
Male
Rabbits
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Wound Healing*
Grant Support
ID/Acronym/Agency:
CA64329/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Endothelial Growth Factors; 0/Intercellular Signaling Peptides and Proteins; 0/Lymphokines; 0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Orthotopic heart transplantation for congenital heart disease: an alternative for high-risk fontan c...
Next Document:  Right ventricle to pulmonary artery conduit improves outcome after stage I Norwood for hypoplastic l...